Rajesh Desai To Retire As Independent Director Of Glenmark Pharmaceuticals

Rajesh Desai will cease to be an Independent Director of Glenmark Pharmaceuticals Limited with effect from June 25, 2025, consequent to the completion of his tenure.

Desai has over 37 years of experience. He previously served as Executive Director and Chief Financial Officer (CFO) at Glenmark until 2016. During his tenure, he led the finance, legal, and IT functions, playing a key role in the company’s growth and development. His leadership helped strengthen Glenmark’s financial strategy and operational framework. Desai’s extensive experience across core business functions and his long association with the organisation provide valuable continuity and perspective, contributing to effective decision-making and Corporate Governance at Glenmark.

a

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: